elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50090381-DFD9B0A9-34A0-4FD8-912F-19BB86623D90
Q50090381-DFD9B0A9-34A0-4FD8-912F-19BB86623D90
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50090381-DFD9B0A9-34A0-4FD8-912F-19BB86623D90
Cytarabine and daunorubicin for the treatment of acute myeloid leukemia.
P2860
Q50090381-DFD9B0A9-34A0-4FD8-912F-19BB86623D90
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50090381-DFD9B0A9-34A0-4FD8-912F-19BB86623D90
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7fc77517f71e54d8eb4e987b083f97f6b597143e
P2860
Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.